Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of p53 in drug resistance in ovarian cancer.

Lancet (London, England) - 15 Mar 1997

Shelling A N

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Drug Resistance, Neoplasm
Share to Genes, p53
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Prognosis

Source

Identifiers

PMID: 9074569
DOI: 10.1016/S0140-6736(05)60195-X

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of p53 in drug resistance in ovarian cancer.PMID 9074569Read ↗

Role of p53 and Rb in ovarian cancer.Semantic proximity Read ↗

Towards the overcoming of anticancer drug resistance mediated by p53 mutations.Semantic proximity Read ↗

Oncogenes associated with drug resistance in ovarian cancerSemantic proximity Read ↗

Effect of p53 Status on Sensitivity to Platinum Complexes in a Human Ovarian Cancer Cell LineSemantic proximity Read ↗

Inactivation of p53 in a Human Ovarian Cancer Cell Line Increases the Sensitivity to Paclitaxel by Inducing G2/M Arrest and ApoptosisSemantic proximity Read ↗

p53 as a potential target in cancer therapy.Semantic proximity Read ↗

TP53 mutations in epithelial ovarian cancerSemantic proximity Read ↗

Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene TargetsSemantic proximity Read ↗

TP53 and ovarian cancer.Semantic proximity Read ↗

Cancer therapy based on p53.Semantic proximity Read ↗

p53 in hematologic malignancies.Semantic proximity Read ↗

Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.